Lost Password? No account yet? Register

Advertisement

New Media Advertisement
Researchers discover - how malaria parasite hijacks human RBCs PDF Print E-mail
User Rating: / 0
PoorBest 

A new study has uncovered an arsenal of proteins produced by the malaria parasite that allows it to hijack and remodel human red blood cells (RBCs), leaving the oxygen-carrying cells stiff and sticky.

Those effects on the blood cells play a major role in the development of malaria, a disease responsible for millions of deaths every year. The research results are reported in the journal Cell. “It's a nice piece of biology revealing how the parasite survives in and totally changes red blood cells,” said Alan Cowman of The Walter and Eliza Hall Institute of Medical Research in Australia. Now that those players have been found, “there may be some way of inhibiting these processes by drugs or possibly a live vaccine.”

Plasmodium falciparum causes the most severe form of malaria in humans with one to three million deaths annually, the researchers said. Once in the blood, multiplication of the parasite inside RBCs (also known as erythrocytes) is responsible for its severity and mortality associated with the disease. After the parasite invades, the red cells undergo profound structural and morphological changes, dramatically altering their physical properties and impairing circulation. In contrast to normal RBCs, parasitized cells are rigid and adhere to the lining of the blood vessels and other cell types.

 

 
< Prev   Next >

Retailing

Kmart Pharmacy has launch of the American Fare Dollar Program, which offers pharmacy customers a choice of 10 over-the-counter (OTC) medications from Kmart's proprietary American Fare brand for only…     Readmore

Image

Outsourcing

The pharmaceutical manufacturers in the United States have attacked the proposed pharma policy of India saying that it would contravene the stated goal of liberalizing the sector, and sought some…     Readmore

Image

Homeopathy

The Homeopatic manufacturing units must fulfill the conditions stated by the government of India under 67-G     Readmore

FDA

Invitrogen Corporation, a provider of essential life science technologies for research, production and diagnostics,  has received U.S. Food and Drug Administration (FDA) premarket approval (PMA) for its SPOT-Light(R) HER2…     Readmore

Biotechnology

Attractive incentives and tax soaps offered by the Malaysian government for the biotech and research based companies is luring some major Indian pharmaceutical players to set up units in…     Readmore

Nanotechnology

The UK Royal Commission has issued a report on the spread of nanomaterials, stating that “urgent action [is] needed on testing and regulation”. In its report the Commission found…     Readmore

Packaging

Bilcare Research has launched a product to help check the menace of counterfeit drugs. The product has a label with a unique bar code made out of nanotechnology and…     Readmore